Acampa Maurizio, Camarri Silvia, Lazzerini Pietro Enea, Guideri Francesca, Tassi Rossana, Valenti Raffaella, Cartocci Alessandra, Martini Giuseppe
Stroke Unit, Department of Neurological and Sensorineural Sciences, Azienda Ospedaliera Universitaria Senese, "Santa Maria alle Scotte" General Hospital, Siena, Italy.
Stroke Unit, Department of Neurological and Sensorineural Sciences, Azienda Ospedaliera Universitaria Senese, "Santa Maria alle Scotte" General Hospital, Siena, Italy.
Int J Cardiol. 2017 Sep 15;243:466-470. doi: 10.1016/j.ijcard.2017.03.129.
Hemorrhagic transformation (HT) is a multifactorial phenomenon and represents a possible complication of ischemic stroke, especially after thrombolytic treatment. Increased arterial stiffness has been associated with intracranial hemorrhage, but there is no evidence of association with HT after thrombolytic therapy. The aim of our study is to investigate a possible link between arterial stiffness and HT occurrence after thrombolytic therapy in patients with ischemic stroke.
We enrolled 258 patients (135 males, 123 females; mean age: 73±12years) with acute ischemic stroke undergoing intravenous thrombolysis or/and mechanical thrombectomy. All stroke patients underwent neuroimaging examination, 24-h heart rate and blood pressure monitoring and brain CT-scan after 24-72h to evaluate HT occurrence. The linear regression slope of diastolic on systolic blood pressure was obtained and assumed as a global measure of arterial compliance, and its complement (1 minus the slope), named arterial stiffness index (ASI), has been taken as a measure of arterial stiffness.
Out of 258, HT occurred in 55 patients. ASI was significantly higher in patients with HT than in patients without HT (0.70±0.12 vs 0.62±0.14, p<0.001). Logistic regression model showed ASI as independent predictors of HT (OR: 1.9, 95% CI: 1.09-3.02, for every 0.2 increase of ASI): in particular, OR was 5.2 (CI: 2.22-12.24) when ASI was >0.71, in comparison with ASI lower than 0.57.
Our results point to arterial stiffness as a novel independent risk factor for HT after ischemic stroke treated with thrombolysis, suggesting a particularly high bleeding risk when ASI is >0.71.
出血性转化(HT)是一种多因素现象,是缺血性卒中的一种可能并发症,尤其是在溶栓治疗后。动脉僵硬度增加与颅内出血有关,但尚无证据表明其与溶栓治疗后的HT有关。我们研究的目的是调查缺血性卒中患者溶栓治疗后动脉僵硬度与HT发生之间的可能联系。
我们纳入了258例接受静脉溶栓或/和机械取栓的急性缺血性卒中患者(135例男性,123例女性;平均年龄:73±12岁)。所有卒中患者均接受神经影像学检查、24小时心率和血压监测,并在24 - 72小时后进行脑部CT扫描以评估HT的发生情况。获得舒张压与收缩压的线性回归斜率,并将其作为动脉顺应性的整体指标,其倒数(1减去斜率),即动脉僵硬度指数(ASI),被用作动脉僵硬度的指标。
258例患者中,55例发生了HT。发生HT的患者ASI显著高于未发生HT的患者(0.70±0.12 vs 0.62±0.14,p<0.001)。逻辑回归模型显示ASI是HT的独立预测因子(OR:1.9,95%CI:1.09 - 3.02,ASI每增加0.2):特别是,当ASI>0.71时,OR为5.2(CI:2.22 - 12.24),而ASI低于0.57时。
我们的结果表明动脉僵硬度是溶栓治疗的缺血性卒中后HT的一个新的独立危险因素,提示当ASI>0.71时出血风险特别高。